Oncolytics Biotech, Inc.

Twitter LinkedIn
  • Home
  • About
    • Our Company
    • Management Team
    • Board of Directors
  • Technology
    • What is Pelareorep?
    • What Does Pelareorep Do?
    • Delivery
    • Intellectual Property
    • Posters & Publications
    • Manufacturing
  • Clinical Trials
    • Clinical Development Plan
    • Collaborators
    • Pipeline
  • Media
    • Press Releases
    • Insights
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock Information
    • Filings & Financials
    • Corporate Governance
    • FAQs
    • Email Alerts
    • IR Contacts
  • Contact
  • Careers

News

Media

Media

  • Press Releases
  • Insights
Feb 22, 2007

Oncolytics Biotech Inc. Announces Closing of Public Share Offering

Feb 6, 2007

Oncolytics Biotech Inc. Announces Pricing of Previously Announced Public Offering

Feb 5, 2007

Oncolytics Biotech Inc. Announces Public Offering

Jan 23, 2007

Oncolytics Biotech Inc. Announces Appointment of Vice President, Intellectual Property

Jan 16, 2007

Oncolytics Biotech Inc. Announces Issuance of 18th U.S. Patent

Jan 10, 2007

Oncolytics Biotech Inc. Research Collaborators to Present Reovirus Data at Society of Academic & Research Surgery Conference

Jan 3, 2007

Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Gemcitabine

Jan 3, 2007

Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Docetaxel

    • 1...
    • 50
    • 51
    • 52
    • 53
    • 54
    • 55
    • 56
    • 57
    • 58
    • 59
    © 2023 Oncolytics Biotech, Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap